Tracey Roberts
Partner
Tracey is an intellectual property litigator in the life sciences sector, who studied Natural Sciences specialising in pathology. Tracey's principal expertise is in leading high-profile, multi-jurisdictional patent cases where she coordinates litigation strategy across Europe and worldwide, acting for both innovator and generic/biosimilar clients.
Tracey's experience
-
Coordinated litigation in the UK, Italy, Switzerland, the Netherlands and at the EPO for the European-wide launch of a generic company product for iron overload.
- Cross-border
- Technology, Science & Industry
-
Advised Teva Pharmaceutical Ltd in their patent litigation against BioMarin in respect of the product sapropterin, a life-changing drug for PKU sufferers. A campaign by a cross party group of MPs and the Daily Express to make this drug available shone a light on its importance for patients.
- Cross-border
- Technology, Science & Industry
-
Advised a large biotech company on a potential preliminary injunction action in the Netherlands to facilitate market access for their rheumatoid arthritis and ulcerative colitis biosimilar.
- Cross-border
- Technology, Science & Industry
-
Advised Teva Pharmaceutical Industries Ltd in their successful 2022 trial against Novartis in respect of their deferasirox product. The case considered important legal question about numerical limits in respect of the Doctrine of Equivalents and the role of the Skilled Team.
- Cross-border
- Technology, Science & Industry
-
Acted for Teva Pharmaceutical Industries Ltd in respect of their mirabegron product, co-counselling alongside Sandoz, in a case that considered key issues of plausibility at the UK trial.
- Cross-border
- Technology, Science & Industry
-
Advised a large biopharmaceutical biosimilar manufacturer on orphan drug exclusivities in respect of the launch of their biosimilar for treatment of blood disorders.
- United Kingdom
- Technology, Science & Industry
-
Acted in patent proceedings for Teva Industries Ltd against Chiesi in respect of a combination of beclomethasone dipropionate and formoterol fumarate to treat asthma and COPD. This led to a precedent setting UK ruling on the threshold for a threat of patent infringement.
- United Kingdom
- Technology, Science & Industry
-
Acted for Roche in defence of a UK invalidity action of a patent (concerning the glycosylation of antibodies) brought by Takeda and a counterclaim for infringement in respect of Takeda’s monoclonal antibody vedolizumab (Entyvio) for the treatment of ulcerative colitis and Crohn's disease.
- United Kingdom
- Technology, Science & Industry
-
Coordinated parallel proceedings for Amgen in their PCSK9 case against Sanofi in the EPO, France and Germany.
- Cross-border
- Technology, Science & Industry
-
Acted for Amgen in an infringement claim against Sanofi and Regeneron for the sale of their monoclonal antibody alirocumab (Praluent), which inhibits PCSK9 (a molecule involved in the regulation of low-density lipoprotein (LDL) receptors) and a counterclaim for revocation of Amgen’s patent for antibodies to PCSK9.
- United Kingdom
- Technology, Science & Industry
Credentials
-
2023Made Partner at Pinsent Masons
-
2020Admitted to the Irish Roll of Solicitors
-
2019Joined Pinsent Masons
-
2015Oxford University - Post Graduate Diploma in Intellectual Property Law
-
2013Marks & Clerk Solicitors LLP - Associate
-
2012Linklaters LLP - Associate
-
2012Qualified, England & Wales
-
2010Linklaters LLP - Trainee
-
2009College of Law - Legal Practice Course
-
2008College of Law - Postgraduate Diploma in Law
-
2007University of Cambridge - MA (Cantab) Natural Sciences
Out-Law / Insight by Tracey Roberts
People who viewed Tracey Roberts also viewed
Show me all
Désirée Fields
Legal Director
Désirée advises on worldwide trade mark and design portfolio management, international prosecution and clearance, enforcement, exploitation and commercialisation of trade marks and designs.
Dinesh Banani
Partner
Dinesh is our Head of US Securities and has been guiding corporates and investment banks through equity and debt capital markets transactions in the UK, Europe, Middle East, Africa and Asia for the last 20 years.
David Barker
Global Sector Head for Technology, Science and Industry
David is our Sector Head for Technology, Science and Industry and leads our global offering to clients in these sectors. He is recognised as a market leader in technology and privacy litigation, having acted in some of the most complex and groundbreaking litigation in the tech space.
David Doogan
Partner
David acts for Lenders and Borrowers and specialises in the finance aspects of a wide variety of corporate transactions including corporate lending (secured and unsecured), property finance transactions (both investment and development), acquisition finance and leveraged transactions, corporate reorganisations and receivables financing transactions.